Sentrex Health Solutions, in Collaboration With the Fatty Liver Alliance and Advanced Liver Imaging to Host a Community Liver He
LONDON, Ontario , May 31 /Businesswire/ - Sentrex Health Solutions, in collaboration with Advanced Liver Imaging and the Fatty Liver Alliance, is proud to announce a community liver health event aimed at raising awareness about non-alcoholic fatty liver disease (NAFLD) and its more serious form, non-alcoholic steatohepatitis (NASH). In recognition of International NASH day, the London Liver Center will be hosting a community educational event that will take place on June 10th at the London Liver Center located in Suite #266, 230 Victoria Street, London.
NAFLD and NASH are rapidly emerging as significant health concerns globally. These conditions are characterized by the accumulation of fat in the liver, leading to inflammation and potential liver damage. With the increasing prevalence of obesity and sedentary lifestyles, it is crucial to educate the community about the risk factors, prevention, and management strategies associated with these diseases.
The London Liver Center will be offering free Fibroscan® assessments during the event. A fibroscan® is a non-invasive and painless diagnostic procedure that measures the stiffness of the liver and provides valuable insights into the health of liver. The test takes about 5 minutes to complete. Anyone interested in receiving a Fibroscan® test can book their free appointment in advance by visiting our Calendly page at https://calendly.com/sentrexliverhealth/fibroscan
"We believe that prevention and early detection are key to addressing liver diseases such as NAFLD and NASH," said Dr. Paul Marotta, a leading hepatologist at the London Liver Center. "By hosting this community event, we aim to raise awareness and empower individuals to take control of their liver health through education and proactive healthcare measures."
Event Details:
The liver health event is open to the general public, healthcare professionals, and anyone interested in learning more about NAFLD and NASH. Attendees will have the opportunity to engage in informative discussions, ask questions to experts, and connect with local resources for ongoing support. Fibroscan® assessments must be pre-booked in advance.
About Sentrex Health Solutions:
Sentrex Health Solutions is a Canadian company that specializes in patient support services across several therapeutic areas, including Hepatology. We are passionate about improving the lives of patients living with or at-risk of developing liver disease.
About London Liver Center:
The London Liver Center is a leading healthcare provider dedicated to delivering comprehensive, patient-centered care. With a focus on liver health and a team of experienced medical professionals, the London Liver Center strives to make a positive impact on the well-being of the community.
Advanced Liver Imaging:
Advanced liver imaging is a leading provider of diagnostic services for patients with liver disease. Affiliated with the London Liver Center, Advanced Liver Imaging provides access to novel diagnostic tools including transient elastography (Fibroscan®) and 2D Shear wave elastography (SWE), two of the most common recommended diagnostic tests to assess the health of the liver.
About Fatty Liver Alliance:
Fatty Liver Alliance is a trusted not-for-profit charitable organization that raises awareness and educates Canadians about the risks, causes and complications of fatty liver disease and by advocating for access to approved treatments and care for those who already have NAFLD and NASH
About International NASH Day:
International NASH Day is an annual public education campaign dedicated to raising awareness about non-alcoholic steatohepatitis (NASH), a severe form of fatty liver disease. Held on June 8th this year, this global initiative aims to educate the public, healthcare professionals, and policymakers about the growing prevalence and impact of NASH on individuals and communities worldwide. For more information, visit https://www.international-nash-day.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20230531005688/en/